Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted and appeared in  ObesityPublic HealthIssue 729

AACE Announces a New Medically-Actionable Diagnosis of Obesity

An advanced framework for a new diagnostic approach to obesity was announced last week by the American Association of Clinical Endocrinologists (AACE) at their 23rd Scientific and Clinical Congress.... 

Advertisement

An emergent concept from the Consensus Conference on Obesity, convened by AACE and the American College of Endocrinology (ACE) in March 2014, was that the current diagnostic definition of obesity, which relied on an anthropomorphic measure of body mass index (BMI), needed to be updated. BMI alone does not indicate how weight gain might be affecting the health of individual patients, and multiple stakeholders at the Consensus Conference saw this as a major obstacle to concerted action in combatting obesity.

The new obesity definition and diagnostic strategy is actionable, medically-meaningful and adds value to the health-promoting effects of weight loss.

Dr. W. Timothy Garvey, Chair of the AACE/ACE Consensus Conference on Obesity and Obesity Scientific Committee and author of the AACE/ACE Obesity Consensus Statement, added that, "This approach addresses a problem of diagnostic uncertainty and is the first step in removing the impediment for concerted and comprehensive action among health care professionals, health care systems, regulators, payers, and employers."

In 2011, AACE/ACE declared obesity as a chronic disease as did the American Medical Association in June 2013.

The new approach does not simply depend upon BMI alone, but also the impact of weight gain on health. A four-step approach is recommended for all patients: screening using BMI with adjustments for ethnic differences, clinical evaluation for the presence of obesity-related complications using a checklist, staging for the severity of complications using complication-specific criteria, and selection of prevention and/or intervention strategies targeting specific complications as guided by the AACE/ACE obesity management algorithm.

The next steps will be to obtain broad input and recommendations regarding the framework for the new diagnostic approach from participants at the Consensus Conference on Obesity. The goal is to assure broad-based acceptance, translation, and implementation of the diagnosis that will support concerted action around a rational and comprehensive plan to prevent and treat obesity.

Presented at the 2015 Meeting of the American Association of Clinical Endocrinologists. 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 16 May, 2014 and appeared in  ObesityPublic HealthIssue 729

Past five issues: Diabetes Clinical Mastery Series Issue 225 | Issue 765 | Diabetes Clinical Mastery Series Issue 224 | Issue 764 | Diabetes Clinical Mastery Series Issue 223 |

2014 Most Popular Articles:

Significant Weight Loss and Drop in A1c with New Combo of Lorcaserin and Phentermine
Posted January 16, 2015
ADA Issues New Standards of Medical Care for Diabetes
Posted January 02, 2015
Handbook of Diabetes, 4th Ed., Excerpt #25: Specific Circumstances that Affect Diabetes Control
Posted January 04, 2015
Dr. Timothy Garvey on Qsymia and Other New Therapies for Weight Loss
Posted January 12, 2015
New Guideline Released on Pharmacological Management of Obesity
Posted January 23, 2015
New Guidelines Recommend Off-Loading to Increase Likelihood of Diabetic Foot Ulcer Healing
Posted December 26, 2014
For Your Patients: Practical Advice to Rev Up Your Workouts and Lower Fatigue
Posted January 09, 2015
Phentermine and Topirimate ER (Qsymia) Studied for Type 2 Diabetes Patients
Posted January 15, 2015
FDA Approves Weight-management Drug Saxenda
Posted December 26, 2014
Advancement in the Artificial Pancreas
Posted December 26, 2014


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
Will you prescribe inhaled insulin (Afrezza) when it becomes available this year?
CME/CE of the Week
Warren Joseph, DPM, FIDSA

Category: Wound Care
Credits: .75



Search Articles On Diabetes In Control